Researchers from The University of Manchester studying a rare and potentially lethal childhood disease – which is the clinical opposite of diabetes – have made an important discovery.
Previously it was thought only babies with the most severe form, known as persistent CHI, were at risk of brain damage. The study, published in the journal Frontiers in Endocrinology, will now inform paediatric practice.
CHI is a disease which affects newborn babies where their bodies produce far too much insulin and as a result their blood sugars are very low. It was already known babies born with the persistent form of CHI were at risk of brain damage and developmental delay but it was always believed that the transient form of CHI was less severe and did not carry the same risks.
Dr Karen Cosgrove, from the University’s Faculty of Life Sciences who helped to carry out the study, said: “Our new research proves it is important for all babies with CHI to be treated promptly to prevent low blood sugars occurring.”
Researchers from the University’s Faculty of Life Sciences and Faculty of Medical and Human Sciences along with consultants from the Royal Manchester Children’s Hospital part of Central Manchester University Hospitals NHS Foundation Trust teamed up for the research. Royal Manchester Children’s Hospital is the base for the Northern Congenital Hyperinsulinism (NORCHI) service which is a highly specialised service for the treatment of this condition.
The study found that a third of children have evidence of brain damage from low blood sugars occurring at an early age.
Professor Peter Clayton, Professor of Child Health and Paediatric Endocrinology, said: “Based on these findings, the team recommends that any baby with CHI, whether they turn out to have transient or persistent CHI, should have immediate and sustained treatment of low blood sugar to prevent long-term disability.”
Doctor Indi Banerjee, Consultant in Paediatric Endocrinology at Royal Manchester Children’s Hospital and clinical lead for NORCHI, said: “It has long been recognised that low blood sugars in these babies can cause brain damage. This research shows the damage happens even in children with the milder version of the disease, where low sugars improve after a few days. The damage to the developing brain in these children can be prevented by promptly recognising and correcting the low blood sugars.”
The research has been published in Frontiers in Endocrinology to view the paper, click here.
Professor Peter Clayton, from The University of Manchester, is also Director: Greater Manchester, Lancashire & South Cumbria Medicines for Children Research Network and Associate Director: Greater Manchester Comprehensive Local Research Network
The University of Manchester